ANI Pharmaceuticals, Inc.
NASDAQANI Pharmaceuticals enters the back half of 2026 with a clear tension: the stock is up 8% on the week, but short sellers have been quietly rebuilding positions all month even as analysts grow more divided on whether Cortrophin can deliver. The most striking data point this week is the pace of short accumulation. Short interest has climbed nearly 47% over the past month, now running…
Snapshot as of 23 Sept 2026
ANI Pharmaceuticals enters the back half of 2026 with a clear tension: the stock is up 8% on the week, but short sellers have been quietly rebuilding positions all month even as analysts grow more divided on whether…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ANIP — free to start on ORTEX.
Sign up for free →Open ANIP on ORTEX